The drug Allocetra saves the lives of patients in a severe condition from the virus in Israel. The end of the Phase 2 trial is about to be published soon. preventing or treating complications associated with sepsis, COVID-19, bone-marrow transplants and solid tumors. At the end of 2021, the drug report on patients will be published. Last chance before takeoff. Opinion only not a professional recommendation.